Bond Market’s Mood Shifts Into Safety Mode
Investors shouldn't buy into the high-yield bond market, but they should study it for hints of where stocks are headed, Ron DeLegge writes.
Is the Biotech Party Over?
Should investors bail out of biotech, which has lost almost 25% since late July, or short the sector?
ETF Cores and Satellites
With so many ETF strategies to choose from, advisors need a timeless and proven strategy for building and managing client ETF portfolios.
3 Investing Lessons From Rising Volatility
Intense market volatility can and should be used to an investor’s advantage.
Is This a Bear Market or a Correction?
When stocks sink, it’s time to review both terminology and history, Ron DeLegge writes.
MLPs Follow Energy Prices Lower
While energy MLPs have shadowed energy prices by declining too, they’ve held up much better relative to crashing oil prices.
Are Small Companies the Market’s Achilles Heel?
The demand for safer stocks may be yet another warning sign of turbulence ahead, Ron DeLegge writes.
Icahn, Fink Clash Over Junk Bonds
Investing titan Carl Icahn and BlackRock CEO Larry Fink spar over high-yield debt and the ETFs that invest in it.
S&P 500’s Winning Streak Tops 1,370 Days
How does today's market rise compare with other bull runs?
Is Gold Dead Money?
Gold is routinely and proudly declared a “safe haven.” But it hasn’t been very safe in 2015, despite problems in Greece and elsewhere, DeLegge writes.